News

For five years, the clinical-stage pharmaceutical company has developed Enbumyst, a nasal spray intended to remove excess ...
Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.
The FDA has expanded the approval of Valtoco (diazepam nasal spray) to include treatment of seizure clusters in patients aged 2 to 5 years.
Nasal decongestant sprays are a popular remedy for relieving nasal congestion caused by colds, allergies and sinus infections ...
DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...
An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...
ARS Pharmaceuticals (NASDAQ:SPRY) has signed a four-year agreement with ALK-Abelló A/S to co-promote neffy, its epinephrine ...
Police said that some kids were using “flatulence spray,” also known as fart spray, near the carnival exit, causing groups to run from the smell. They said that the prank was repeated multiple ...
Previously called STS101, the company said Wednesday that the drug’s brand name is Atzumi and is indicated for acute migraine ...
A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By ...
One of the most concerning side effects of overusing nasal sprays is a condition known as rebound congestion, or rhinitis medicamentosa (RM). This occurs when the nose becomes reliant on the spray to ...
Taking over-the-counter medications. Examples include: expectorants such as guaifenesin (Mucinex) decongestants such as oxymetazoline nasal spray (Afrin, Sudafed OM) pseudoephedrine (Contac 12 ...